Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women
Supportive Care in Cancer · 2024
DOI: 10.1007/s00520-024-08463-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Amy Y Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Wisconsin, 8701 W Watertown Plank Rd, Milwaukee, WI, 52336, USA. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Medical College of Wisconsin Ann E Heil Endowment in Cancer Research, National Institute on Aging.
Abstract (Originalsprache)
PURPOSE: Oral adjuvant endocrine therapy (AET) is an effective treatment for hormone receptor positive breast cancer to decrease recurrence and mortality, but adherence is poor. This study explored post-menopausal women's experiences with AET, with a particular focus on adherence to AET as well as distress and symptoms experienced prior to and during AET treatment. METHODS: Participants were recruited from a hospital registry, stratified by adherence to/discontinuation of AET. Telephone interviews followed a semi-structured interview guide and were recorded and transcribed verbatim. Transcripts were systematically coded using team-based coding, with analysis of themes using a grounded theory approach. RESULTS: Thirty-three participants were interviewed; ages ranged from 57 to 86 years. Participants included 10 discontinued patients and 23 patients who completed their AET course or were adherent to AET at the time of interviewing. Both adherent and discontinued patients reported symptoms throughout their AET treatment course, and both attributed symptoms to factors other than AET (e.g., older age and pre-existing comorbidities). However, discontinued patients were more likely to attribute symptoms to AET and to describe difficulty managing their symptoms, with some directly citing symptoms as the reason for discontinuing AET therapy. Conversely, adherent patients were more likely to describe the necessity of taking AET, despite symptoms. CONCLUSIONS: AET adherence was associated with beliefs about AET, symptom attribution, and symptom management. Routine symptom monitoring during AET and addressing both symptoms and patients' understanding of their symptoms may promote adherence to AET.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical College of Wisconsin, 8701 W Watertown Plank Rd, Milwaukee, WI, 52336, USA.
- Medical College of Wisconsin, 8701 W Watertown Plank Rd, Milwaukee, WI, 52336, USA. kflynn@mcw.edu.
Förderung
- NIA NIH HHS
- Medical College of Wisconsin Ann E Heil Endowment in Cancer Research
- National Institute on Aging
Zitieren
APA
Lee, A. Y., Lyons, A. T., Makris, V., Kamaraju, S., Stolley, M. R., Neuner, J. M., & Flynn, K. E. (2024). Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08463-w
Vancouver
Lee AY, Lyons AT, Makris V, Kamaraju S, Stolley MR, Neuner JM, et al. Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08463-w
BibTeX
@article{Lee2024,
author = {Lee, Amy Y and Lyons, Anna T and Makris, Vaia and Kamaraju, Sailaja and Stolley, Melinda R and Neuner, Joan M and Flynn, Kathryn E},
title = {Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women},
journal = {Supportive Care in Cancer},
year = {2024},
doi = {10.1007/s00520-024-08463-w}
}
EUVIMED